Cargando…
Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
PURPOSE: In the present study, we aimed to evaluate the expression of programmed death-ligand 1 (PD-L1) in patients with non-small cell lung cancer (NSCLC) by radiomic features of (18)F-FDG PET/CT and clinicopathological characteristics. METHODS: A total 255 NSCLC patients (training cohort: n = 170;...
Autores principales: | Li, Jihui, Ge, Shushan, Sang, Shibiao, Hu, Chunhong, Deng, Shengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716940/ https://www.ncbi.nlm.nih.gov/pubmed/34976829 http://dx.doi.org/10.3389/fonc.2021.789014 |
Ejemplares similares
-
Prognostic value of (18)F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study
por: Li, Jihui, et al.
Publicado: (2022) -
Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023) -
Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021) -
Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics
por: Jia, Tongtong, et al.
Publicado: (2023) -
Prognostic Value of Radiomic Features of (18)F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells
por: Zhou, Yeye, et al.
Publicado: (2022)